Stockreport

Aclaris Therapeutics Updates ATI-052 Phase 1 Data, Picks ATI-2138 for Phase 2b in Lichen Planus [Yahoo! Finance]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF could support dosing as infrequently as once every three months, plus robust PD (100% inhibition of TSLP-stimulated CCL17 through 20 weeks at 480 mg) and no safety signa [Read more]